Stocktoria
SUPERNUS PHARMACEUTICALS, INC. SUPN
SUPERNUS PHARMACEUTICALS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 10,392,636 | $278.0M | 18.09% |
| MILLENNIUM MANAGEMENT LLC | 3,315,973 | $171.4M | 5.77% |
| RENAISSANCE TECHNOLOGIES LLC | 1,705,222 | $88.1M | 2.97% |
| CITADEL ADVISORS LLC | 1,528,046 | $79.0M | 2.66% |
| Point72 Asset Management, L.P. | 1,318,555 | $68.2M | 2.29% |
| D. E. Shaw & Co., Inc. | 622,450 | $32.2M | 1.08% |
| TWO SIGMA INVESTMENTS, LP | 271,228 | $14.0M | 0.47% |
| AQR CAPITAL MANAGEMENT LLC | 98,257 | $5.1M | 0.17% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.